We recommend you immediately stop using artificial tears under the brand EzriCare & Delsam Pharma. A summary statement is below. You may read the full statement from the FDA here.
Company Announcement Date:
February 02, 2023
FDA Publish Date:
February 02, 2023
Product Type:
Drugs
Reason for Announcement:
Potential microbial contamination
Company Name:
Global Pharma Healthcare
Brand Name:
EzriCare & Delsam Pharma
Product Description:
Artificial Tears Lubricant Eye Drops Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by /EzriCare, LLC- and Delsam Pharma, to the consumer level, due to possible contamination. The Centers for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo-lactamase (VIM)- and Guiana-Extended Spectrum-Lactamase (GES) producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare. To date, there are 55 reports of adverse events including eye infections, permanent loss of vision, and a death with a bloodstream infection.
Risk Statement: Use of contaminated artificial tears can result in the risk of eye infections that could result in blindness.
